Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma (Q38399485)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma (English)

1 reference

Europe PubMed Central

2 September 2017

8

object named as

Naoya Masumori

1 reference

Europe PubMed Central

2 September 2017

Toshihiko Torigoe

2

object named as

Toshihiko Torigoe

1 reference

Europe PubMed Central

2 September 2017

Yoshihiko Hirohashi

3

object named as

Yoshihiko Hirohashi

1 reference

Europe PubMed Central

2 September 2017

9

object named as

Noriyuki Sato

1 reference

Europe PubMed Central

2 September 2017

4

object named as

Hiroko Asanuma

1 reference

Europe PubMed Central

2 September 2017

Hiroshi Kitamura

1

object named as

Hiroshi Kitamura

1 reference

Europe PubMed Central

2 September 2017

Sachiyo Nishida

6

object named as

Sachiyo Nishida

1 reference

Europe PubMed Central

2 September 2017

Taiji Tsukamoto

10

object named as

Taiji Tsukamoto

1 reference

Europe PubMed Central

2 September 2017

Toshiaki Tanaka

7

object named as

Toshiaki Tanaka

1 reference

Europe PubMed Central

2 September 2017

author name string

Ryuta Inoue

5

1 reference

Europe PubMed Central

2 September 2017

publication date

20 November 2012

1 reference

Europe PubMed Central

2 September 2017

Virchows Archiv

1 reference

Europe PubMed Central

2 September 2017

462

1 reference

Europe PubMed Central

2 September 2017

1

1 reference

Europe PubMed Central

2 September 2017

101-107

1 reference

Europe PubMed Central

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s00428-012-1343-7

0 references

European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Molecular and histological markers in urothelial carcinomas of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear or cytoplasmic expression of survivin: what is the significance?

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Prognostic factors for upper urinary tract urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1343-7

21 January 2018

Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of survivin and its splice variants in tumorigenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular localization of survivin determines biological behavior in colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23179762

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-012-1343-7

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38399485&oldid=1964202825"